Johanna Borg Bruchfeld

4PUBLICATIONS
10CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 30, 2022
Sex differences in lymphoma incidence and mortality by subtype: A population-based study.

Cecilia Radkiewicz, Johanna B Bruchfeld, Caroline E Weibull

|Sep 06, 2019
Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?

Charlotte Gran, Katarina Uttervall, Johanna Borg Bruchfeld

|Jun 25, 2019
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma.

Katarina Uttervall, Johanna Borg Bruchfeld, Charlotte Gran

Pageof 1